Synthetic activation of multimeric transmembrane receptors
AssigneeAarhus Universitet
InventorsKasper Røjkjær ANDERSEN, Elena Simona RADUTOIU, Henriette RÜBSAM, Christina KRÖNAUER, Jens Stougaard JENSEN
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to synthetic approaches based on affinity peptides to drive assembly and activation of transmembrane receptor complexes. The present disclosure further relates to the core NFR1-NFR5 receptor complex initiating the cortical root nodule organogenesis program and the epidermal program, as well as the identification of barley receptor complexes that function in root nodule symbiosis.
Claims28
A genetically modified cell comprising:
- a transmembrane (TM) receptor complex comprising a first subunit polypeptide and a second subunit polypeptide,
- wherein the first subunit polypeptide comprises an affinity polypeptide that binds to the second subunit polypeptide intracellularly inducing oligomerization;
- and
- wherein oligomerization of the first subunit polypeptide and the second subunit polypeptide activates TM receptor signaling, wherein the affinity polypeptide is heterologous to the first subunit polypeptide.
A bispecific affinity polypeptide comprising:
- a first affinity polypeptide that binds to an intracellular portion of a first subunit polypeptide of a TM receptor;
- and
- a second affinity polypeptide that binds to an intracellular portion of a second subunit polypeptide of the TM receptor;
- wherein binding of the first affinity polypeptide to the first subunit polypeptide and of the second affinity polypeptide to the second subunit polypeptide induces oligomerization;
- and
- wherein oligomerization of the first subunit polypeptide and the second subunit polypeptide activates TM receptor signaling.
A method of screening transmembrane (TM) receptor complexes comprising:
- (a) providing a cell expressing a first subunit polypeptide of a TM receptor;
- (b) expressing a second subunit polypeptide of a TM receptor in the cell;
- and
- (c) assaying the cell for a TM receptor phenotype;
- and
- wherein (i) the presence of the TM receptor phenotype indicates the first subunit polypeptide and the second subunit polypeptide oligomerize to form the TM receptor;
- or (ii) the absence of the TM receptor phenotype indicates the first subunit polypeptide and the second subunit polypeptide do not oligomerize to form a TM receptor, and wherein (1) the second subunit polypeptide comprises a tag polypeptide, the first subunit polypeptide comprises an affinity polypeptide that binds to the tag polypeptide, and the affinity polypeptide is heterologous to the first subunit polypeptide, or (2) the first subunit polypeptide comprises the tag polypeptide, the second subunit polypeptide comprises the affinity polypeptide that binds to the tag polypeptide, and the affinity polypeptide is heterologous to the second subunit polypeptide.
An expression vector or isolated DNA molecule comprising one or more nucleotide sequences encoding a first subunit polypeptide of a TM receptor comprising an affinity polypeptide, wherein the affinity polypeptide is heterologous to the first subunit polypeptide, and wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence;
- one or more nucleotide sequences encoding a second subunit polypeptide of a TM receptor optionally comprising a tag polypeptide, wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence;
- one or more nucleotide sequences encoding:
- (a) a first subunit polypeptide of a transmembrane (TM) receptor complex comprising an affinity polypeptide, wherein the affinity polypeptide is heterologous to the first subunit polypeptide;
- and/or (b) a second subunit polypeptide of a TM receptor optionally comprising a tag polypeptide, wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence;
- and/or one or more nucleotide sequences encoding a bispecific affinity polypeptide comprising a first affinity polypeptide that binds to an intracellular portion of a first subunit polypeptide of a TM receptor and a second affinity polypeptide that binds to an intracellular portion of a second subunit polypeptide of a TM receptor, wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence.
A genetically modified plant cell comprising:
- an NFR1-NFR5 receptor complex comprising a first subunit polypeptide and a second subunit polypeptide,
- wherein the first subunit polypeptide comprises an affinity polypeptide that binds to the second subunit polypeptide inducing oligomerization, and wherein the affinity polypeptide is heterologous to the first subunit polypeptide;
- and
- wherein oligomerization of the first subunit polypeptide and the second subunit polypeptide activates NFR1-NFR5 receptor complex signaling and wherein (i) the first subunit polypeptide is an NFR1 polypeptide and the second subunit polypeptide is an NFR5 polypeptide, or (ii) the first subunit polypeptide is the NFR5 polypeptide and the second subunit polypeptide is the NFR1 polypeptide.
A bispecific affinity polypeptide for activation of an NFR1-NFR5 receptor complex comprising:
- a first affinity polypeptide that binds to an intracellular portion of an NFR1 polypeptide;
- and
- a second affinity polypeptide that binds to an intracellular portion of an NFR5 polypeptide;
- wherein binding of the first affinity polypeptide to the NFR1 polypeptide and of the second affinity to the NFR5 polypeptide induces dimerization;
- and wherein dimerization of the NFR1 polypeptide and the NFR5 polypeptide activates NFR1-NFR5 receptor complex signaling.
An expression vector or isolated DNA molecule comprising one or more nucleotide sequences encoding a NFR1 polypeptide comprising an affinity polypeptide, wherein the affinity polypeptide is heterologous to the NFR1 polypeptide, and wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence;
- one or more nucleotide sequences encoding a NFR5 polypeptide optionally comprising a tag polypeptide, wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence;
- one or more nucleotide sequences encoding:
- (a) a NFR1 polypeptide comprising an affinity polypeptide, wherein the affinity polypeptide is heterologous to the first subunit polypeptide;
- and/or (b) a NFR5 polypeptide optionally comprising a tag polypeptide, wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence;
- and/or one or more nucleotide sequences encoding a bispecific affinity polypeptide comprising a first affinity polypeptide that binds to an intracellular portion of a NFR1 polypeptide and a second affinity polypeptide that binds to an intracellular portion of a NFR5 polypeptide, wherein the one or more nucleotide sequences are operably linked to at least one expression control sequence.
Dependencies are inferred from the claim text.